Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Managing Cancer Treatment in Patients With Renal Dysfunction: The Role of Chemotherapy Publisher Pubmed



Aghsaeifard Z1 ; Alizadeh R2
Authors

Source: Anti-Cancer Agents in Medicinal Chemistry Published:2023


Abstract

Malignancy is characterized by damage to several vital organs, and utilizing chemotherapy as a treatment option can have toxic effects on healthy body tissues. Kidney function is commonly compromised by cancer and chemotherapy. These effects can be pre-renal, intrarenal, or postrenal. Tumor lysis syndrome and electrolyte disturb-ances are also common in this group of patients. Etiologies of this dysfunction are poorly understood; therefore, careful monitoring and management of renal function are required in such cases. This narrative review aimed to highlight some of the common renal abnormalities among patients receiving cancer and chemotherapy. © 2023 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Probability of Tumor Lysis Syndrome in Electrochemotherapy of Large Solid Tumors: A Pilot Study, European Journal of Cancer Care (2025)
2. Renal Dysfunction in Individuals With Ovarian Cancer; a Review on Current Concepts, Journal of Renal Injury Prevention (2023)
3. Platinum-Based Chemotherapies-Induced Nephrotoxicity: Mechanisms, Potential Treatments, and Management, International Urology and Nephrology (2025)
Experts (# of related papers)
View all Related Experts
Ziba Aghsaeifard (2)
Kourosh Sadeghi (1)
Other Related Docs
4. Spontaneous Tumor Lysis Syndrome in Adrenal Adenocarcinoma: A Case Report and Review of The Literature, Journal of Medical Case Reports (2022)
5. Impact of Cancers on the Kidney Function and Structure; an Ignored Entity, Journal of Renal Injury Prevention (2018)
6. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
7. Two-Way Road of Kidney and Hypercalcemia: A Narrative Review, Cardiovascular and Hematological Disorders - Drug Targets (2022)
8. Serum Tumor Markers in Chronic Kidney Disease: As Clinical Tool in Diagnosis, Treatment and Prognosis of Cancers, Renal Failure (2016)
9. Molecular Biology, Genetic, and Epigenetics of Kidney Tumor, (2024)
10. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report From a Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial, Phytotherapy Research (2015)
11. Chronic Hemodialysis: Evaluation of Dialysis Adequacy and Mortality, Annals of Medicine and Surgery (2022)
12. Predictors of Acute Kidney Injury in Hematological Cancer Patients: A Prospective Cross-Sectional Study, Turkish Journal of Nephrology (2023)